The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder

ConclusionsShort‐term adjunctive LDX treatment was well tolerated by this sample of adults with stable bipolar I/II disorder. Lisdexamfetamine dimesylate offered beneficial effects on body weight, body mass index and several metabolic parameters. In addition to demonstrating short‐term (i.e., 4 weeks) safety and tolerability, beneficial effects of LDX were also observed in mitigating depressive and ADHD symptom severity. Copyright © 2013 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - September 9, 2013 Category: Psychiatry Authors: Roger S. McIntyre, Mohammad Alsuwaidan, Joanna K. Soczynska, Isaac Szpindel, Timothy S. Bilkey, Doron Almagor, Hanna O. Woldeyohannes, Alissa M. Powell, Danielle S. Cha, Laura Ashley Gallaugher, Sidney H. Kennedy Tags: Research Article Source Type: research